Literature DB >> 9247535

Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy.

P H Pak1, H B Nuss, R S Tunin, S Kääb, G F Tomaselli, E Marban, D A Kass.   

Abstract

OBJECTIVES: This study sought to determine whether the canine model of tachycardia-induced heart failure (HF) is an effective model for sudden cardiac death (SCD) in HF.
BACKGROUND: Such a well established HF model that also exhibits arrhythmias and SCD, along with repolarization abnormalities that could trigger them, may facilitate the study of SCD in HF, which still eludes effective treatment.
METHODS: Twenty-five dogs were VVI-paced at 250 beats/min for 3 to 5 weeks. Electrocardiograms were obtained, and left ventricular endocardial monophasic action potentials (MAPs) were recorded at six sites at baseline and after HF. Weekly Holter recordings were made with pacing suspended for 24 h.
RESULTS: Six animals (24%) died suddenly, one with Holter-documented polymorphic ventricular tachycardia (VT). Holter recordings revealed an increased incidence of VT as HF progressed. Repolarization was significantly (p < 0.05) prolonged, as indexed by a corrected QT interval (mean [+/-SD] 311 +/- 25 to 338 +/- 25 ms) and MAP duration measured at 90% repolarization (MAPD90) (181 +/- 19 to 209 +/- 28 ms), and spatial MAPD90 dispersion rose by 40%. We further tested whether CsCl inhibition of repolarizing K+ currents, which are reportedly downregulated in HF, might preferentially prolong the MAPD90 in HF. With 1 mEq/kg body weight of CsCl, MAPD90 rose by 86 +/- 100 ms in dogs with HF versus only 28 +/- 16 ms in control animals (p = 0.002). Similar disparities in CsCl sensitivity were observed in myocytes isolated from normal and failing hearts.
CONCLUSIONS: Tachycardia-induced HF exhibits malignant arrhythmia and SCD, along with prolonged, heterogeneous repolarization and heightened sensitivity to CsCl at chamber and cellular levels. Thus, it appears to be a useful model for studying mechanisms and therapy of SCD in HF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247535     DOI: 10.1016/s0735-1097(97)00193-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  29 in total

Review 1.  Electrophysiological modeling of cardiac ventricular function: from cell to organ.

Authors:  R L Winslow; D F Scollan; A Holmes; C K Yung; J Zhang; M S Jafri
Journal:  Annu Rev Biomed Eng       Date:  2000       Impact factor: 9.590

Review 2.  The impact of recent ion channel science on the development and use of antiarrhythmic drugs.

Authors:  M N Langan
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

3.  Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.

Authors:  Nazareno Paolocci; Tatsuo Katori; Hunter C Champion; Marcus E St John; Katrina M Miranda; Jon M Fukuto; David A Wink; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

Review 4.  Sudden death in heart failure: underlying electrophysiological mechanisms.

Authors:  Subramaniam C Krishnan; Claudio D Schuger; Sidney Goldstein
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

Review 5.  CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction.

Authors:  Chad E Grueter; Roger J Colbran; Mark E Anderson
Journal:  J Mol Med (Berl)       Date:  2006-11-21       Impact factor: 4.599

6.  Molecular correlates of altered expression of potassium currents in failing rabbit myocardium.

Authors:  Jochen Rose; Antonis A Armoundas; Yanli Tian; Deborah DiSilvestre; Miroslava Burysek; Victoria Halperin; Brian O'Rourke; David A Kass; Eduardo Marbán; Gordon F Tomaselli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-06       Impact factor: 4.733

7.  Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy.

Authors:  Takeshi Aiba; Geoffrey G Hesketh; Andreas S Barth; Ting Liu; Samantapudi Daya; Khalid Chakir; Veronica Lea Dimaano; Theodore P Abraham; Brian O'Rourke; Fadi G Akar; David A Kass; Gordon F Tomaselli
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

Review 8.  Sympathetic nervous system activity and ventricular tachyarrhythmias: recent advances.

Authors:  Kelley P Anderson
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

9.  Paraplegia increased cardiac NGF content, sympathetic tonus, and the susceptibility to ischemia-induced ventricular tachycardia in conscious rats.

Authors:  Heidi L Lujan; Ying Chen; Stephen E Dicarlo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 10.  Tachycardia-mediated cardiomyopathy: recognition and management.

Authors:  Rakesh Gopinathannair; Renee Sullivan; Brian Olshansky
Journal:  Curr Heart Fail Rep       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.